Highlights and Quick Summary
- Accrued Expenses for the quarter ending March 31, 2023 was $4.96 Million (a -22.24% decrease compared to previous quarter)
- Year-over-year quarterly Accrued Expenses increased by 1.95%
- Annual Accrued Expenses for 2022 was $6.38 Million (a -18.83% decrease from previous year)
- Annual Accrued Expenses for 2021 was $7.86 Million (a -2.98% decrease from previous year)
- Annual Accrued Expenses for 2020 was $8.1 Million (a -38.65% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Accrued Expenses of Precigen, Inc.
Most recent Accrued Expensesof PGEN including historical data for past 10 years.Interactive Chart of Accrued Expenses of Precigen, Inc.
Precigen, Inc. Accrued Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $4.96 | – | – | – | – |
2022 | $6.38 | $5.79 | $4.86 | $6.05 | $6.38 |
2021 | $7.86 | $8.08 | $7.77 | $6.43 | $7.86 |
2020 | $8.1 | $7.57 | $7.72 | $7.21 | $8.1 |
2019 | $13.2 | $9.86 | $9.03 | $7.78 | $13.2 |
2018 | $9.96 | $23.89 | $14.02 | $11.36 | $9.96 |
2017 | $6.47 | $11.21 | $9.1 | $7.48 | $6.47 |
2016 | $6.54 | $11.01 | $9.47 | $8.28 | $6.54 |
2015 | $19.05 | $14.48 | $12.43 | $8.03 | $19.05 |
2014 | $7.74 | $6.7 | $4.09 | $2.76 | $7.74 |
2013 | – | $5.16 | $3.69 | $3.32 | $5.16 |
2012 | – | – | – | – | $3.77 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology